{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:51:27Z","timestamp":1784616687078,"version":"3.55.0"},"reference-count":13,"publisher":"Cold Spring Harbor Laboratory","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cold Spring Harb Mol Case Stud"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Li\u2013Fraumeni syndrome (LFS) is an autosomal dominant cancer predisposition syndrome caused by germline alterations in the tumor suppressor gene <jats:italic>TP53<\/jats:italic>. LFS is associated with numerous malignancies including astrocytoma. Sanger sequencing and chromosomal microarray studies of blood and tumor tissue from a 4-yr-old boy with glioblastoma demonstrated a germline <jats:italic>TP53<\/jats:italic> mutation with loss of heterozygosity for the short arm of Chromosome 17 as the second inactivating event in the tumor. There was no family history of LFS, but the child's mother had recently died from metastatic choriocarcinoma after antecedent normal term delivery of a then 6-mo-old daughter. The choriocarcinoma contained the same <jats:italic>TP53<\/jats:italic> mutation detected in the proband and the 6-mo-old daughter was confirmed to be a carrier. Unexpectedly, the germline <jats:italic>TP53<\/jats:italic> mutation was found to be inherited from the unaffected father. We report here the second genetically confirmed case of <jats:italic>TP53<\/jats:italic>-mutated choriocarcinoma in the partner of an LFS patient. Based on this case and recent literature, female partners of LFS patients may have increased risk of choriocarcinoma due to transmission of germline <jats:italic>TP53<\/jats:italic> mutation from male carriers. Although the Toronto protocol has established an effective approach to detect tumors and improve survival in children and adults with LFS, there is a need to expand the current criteria to include surveillance of female partners of LFS patients for choriocarcinoma and other gestational trophoblastic disease. Recognition of this unique mode of transmission of <jats:italic>TP53<\/jats:italic> mutations should be considered in genetic counseling for cancer risk assessment and family planning.<\/jats:p>","DOI":"10.1101\/mcs.a002576","type":"journal-article","created":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T21:15:23Z","timestamp":1522098923000},"page":"a002576","source":"Crossref","is-referenced-by-count":13,"title":["Transmission of a <i>TP53<\/i> germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner"],"prefix":"10.1101","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1420-3314","authenticated-orcid":false,"given":"Jennifer A.","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Karimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Boghossian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Margol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita","family":"Tamrazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Isaac","family":"Varaprasathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Parham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Judkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn A.","family":"Biegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"246","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"2021112506151058000_4.2.a002576.1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-017-9996-7","article-title":"Gestational choriocarcinoma associated with a germline TP53 mutation","volume":"17","year":"2018","journal-title":"Fam Cancer"},{"key":"2021112506151058000_4.2.a002576.2","first-page":"119","article-title":"p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma","volume":"43","year":"1998","journal-title":"J Reprod Med"},{"key":"2021112506151058000_4.2.a002576.3","first-page":"2745","article-title":"Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells","volume":"9","year":"1994","journal-title":"Oncogene"},{"key":"2021112506151058000_4.2.a002576.4","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.216"},{"key":"2021112506151058000_4.2.a002576.5","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgt161"},{"key":"2021112506151058000_4.2.a002576.6","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijgo.2015.06.008","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"131","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2021112506151058000_4.2.a002576.7","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102853"},{"key":"2021112506151058000_4.2.a002576.8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1470-2045(16)30382-5","article-title":"Improvement of outcomes for TP53 carriers","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"2021112506151058000_4.2.a002576.9","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/PAS.0000000000000937","article-title":"Choriocarcinoma in women: analysis of a case series with genotyping","volume":"41","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2021112506151058000_4.2.a002576.10","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.233"},{"key":"2021112506151058000_4.2.a002576.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30249-2"},{"key":"2021112506151058000_4.2.a002576.12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.75"},{"key":"2021112506151058000_4.2.a002576.13","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.3"}],"container-title":["Molecular Case Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/mcs.a002576","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T14:15:28Z","timestamp":1637849728000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularcasestudies.cshlp.org\/lookup\/doi\/10.1101\/mcs.a002576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,4,2]]},"published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1101\/mcs.a002576"],"URL":"https:\/\/doi.org\/10.1101\/mcs.a002576","relation":{},"ISSN":["2373-2865","2373-2873"],"issn-type":[{"value":"2373-2865","type":"print"},{"value":"2373-2873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,26]]}}}